News Teva collaborates with Intel to develop Huntington's smartwa... Teva enters the machine learning market.
Views & Analysis Digital Health Round-up – Verily's diabetes ambitions; IBM W... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Stanford and twoXAR strike deal to take on liver cancer Stanford University School of Medicine is to take on liver cancer by teaming with twoXAR to develop new drug candidates.
News Artificial Intelligence can improve lung disease diagnosis Algorithm demonstrates ability to analyse complete lung function test results.
Views & Analysis Digital Health Round-up – DeepMind & UCLH; Google Glass A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Digital health round-up: Apple buys Gliimpse; NHS Trusts sha... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
